Anti-Influenza A virus HA/Hemagglutinin Reference Antibody (Diridavumab, RUO)

SKU: VK515016

Size:100ug

Description:Diridavumab, the alternative name, CR6261, is a human monoclonal antibody directed against influenza A hemagglutinin. The CR6261 antibody was first discovered by the Scripps Institute and Crucell, a Dutch biopharmaceutical company, and later developed by Janssen Pharmaceutical Companies of Johnson & Johnson under the trade name diridavumab. Cr6261 is under investigation in clinical trial NCT02016066 (A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of Diridavumab in Japanese Healthy Participants).

Host species:Human

Tested applications:

Species reactivity:Influenza A virus

Form:Liquid

Storage buffer:0.01M PBS, pH 7.4.

Purity:>95% purity as determined by SDS-PAGE.

Clonality:Monoclonal

Isotype:IgG1, lambda

Applications:ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Target:HA/Hemagglutinin

Purification:Protein A/G purified from cell culture supernatant.

Endotoxin level:Please contact us for this information.

Expression system:Mammalian Cells

Accession:P03455

Stability and Storage:Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.

Reconstitution:

Background:

Alternative Names:CR-6261, CR6261, 1393659-46-5

Clone ID:

Species:

Note:For research use only. Not suitable for clinical or therapeutic use.